GlassScriptPhysician profile
Max V Morales
NPI 1023768728
$3,279.71
in general payments reported to CMS, 2019-2025
9 companies · $1,558 in 2025
The $1,558 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,313 · 2024: $409 · 2025: $1,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682 · Travel and Lodging: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.04 |
| Travel and Lodging | $1,597.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $1,312.78 | 2023 | |
| Treace Medical Concepts, INC. | $1,155.55 | 2024-2025 | |
| Biotissue Holdings INC. | $242.15 | 2024 | |
| Depuy Synthes Sales INC. | $146.99 | 2025 | Dynacord |
| Bioventus LLC | $139.59 | 2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $129.85 | 2025 | Puraply Wound Matrix, Simplimax, Via Matrix |
| Averitas Pharma INC. | $87.76 | 2025 | Qutenza |
| Amgen INC. | $44.32 | 2025 | Krystexxa |
| Abbvie INC. | $20.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.